Contact Us
Drug Search Results
More Filters [+]

Tiratricol

Alternative Names: tiratricol, triac
Latest Update: 2024-11-12
Latest Update Note: News Article

Product Description

Rare Thyroid Therapeutics International is developing Tiratricol as a treatment for Allan-Herndon-Dudley Syndrome. (Sourced from: https://classic.clinicaltrials.gov/ct2/show/NCT02396459)

Mechanisms of Action: THR Binder

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Topical,Percutaneous,Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Argentina | Brazil | Chile | Colombia | France | Hong Kong | Peru | United Kingdom | Uruguay

Approved Indications: None

Known Adverse Events: None

Company: Rare Thyroid Therapeutics International
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Tiratricol

Countries in Clinic: Czech Republic, Netherlands, United Kingdom, United States

Active Clinical Trial Count: 3

Highest Development Phases

Phase 3: Allan-Herndon-Dudley Syndrome|Mental Retardation, X-Linked|Muscle Hypotonia|Muscular Atrophy

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
MCT8-2019-2

P2

Unknown Status

Allan-Herndon-Dudley Syndrome

2026-09-07

ReTRIACt

P3

Recruiting

Muscle Hypotonia|Muscular Atrophy|Allan-Herndon-Dudley Syndrome|Mental Retardation, X-Linked

2025-04-01

MCT8-2021-3

P3

Unknown Status

Allan-Herndon-Dudley Syndrome

2025-02-28

Recent News Events

Date

Type

Title

11/12/2024

News Article

 Tivoli Lighting Expands Color Options With Flexile LG and SM Series for More Creative Options for Architectural Aesthetic Applications

06/04/2024

News Article

 Tivoli Lighting Introduces Natura Turtle Safe LED Tape Light

04/01/2024

PubMed

 Effective TRIAC treatment of a THRbeta-mutated patient with thyroid hormone resistance.

03/12/2024

PubMed

 Glycerol Phenylbutyrate treatment of two patients with Monocarboxylate Transporter 8 deficiency.

02/20/2024

PubMed

 Impaired T3 uptake and action in MCT8-deficient cerebral organoids underlie Allan-Herndon-Dudley syndrome.

11/23/2023

News Article

 Industrial Relays Market to grow by USD 1.40 billion from 2022 to 2027; The enhanced reliability and durability of industrial relays to drive the growth- Technavio

10/19/2023

News Article

 Power Electronics Market Intense Competition but High Growth & Extreme Valuation

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions